Abstract
Lower urinary tract symptoms (LUTS) in men are due to bladder dysfunction or bladder outlet disorders such as benign prostatic enlargement and bladder neck or urethral sphincter dysfunction. Men with lower urinary tract symptoms prefer shared problem-solving and decision making during treatment planning. Urodynamic studies (UDS) in male LUTS (MLUTS) are useful for both diagnosis and prognosis. UDS help both the clinician and the patient in shared decision making regarding treatment of these men. The AUA/SUFU guidelines and EAU guidelines are helpful in cost-effective selection of patients with MLUTS for urodynamic evaluation. UDS are indicated in the subset of patients with MLUTS being considered for invasive and potentially morbid therapy. Uroflowmetry and post-void residual (PVR) volume measurement by bladder ultrasound scan are good screening tests in MLUTS. Urodynamic evidence of bladder outlet obstruction has been correlated with better outcomes following invasive therapy.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Wei JT, Calhoun E, Jacobsen SJ. Urologic diseases in America project: benign prostatic hyperplasia. J Urol. 2005;173(4):1256–61.
Andersson SO, Rashidkhani B, Karlberg L, et al. Prevalence of lower urinary tract symptoms in men aged 45–79 years: a population-based study of 40,000 Swedish men. Br J Urol. 2004;94(3):327–31.
Collins CW, Winters JC. AUA/SUFU Adult Urodynamics Guideline. A clinical review. Urol Clinics North Am. 2014;41:353–62. A total of 19 Guidelines Statements in each of the 4 lower urinary tract conditions were presented in this manuscript with each guideline statement discussed in the context of clinical cases.
McVary KT, Roehrborn CG, Avins AL, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol. 2011;185(5):1793–803. The authors revised the 2003 version of the American Urological Association’s (AUA) Guideline on the management of benign prostatic hyperplasia (BPH) in this manuscript.
Winters JC, Dmochowski RR, Goldman HB, et al. Urodynamic studies in adults: AUA/SUFU guideline. J Urol. 2012;188 Suppl 6:2464–72. The manuscript is aimed to help the clinician in appropriate selection of urodynamic tests in common lower urinary tract symptoms following the basic clinical evaluation.
Abrams P, Chapple C, Khoury S, et al. Evaluation and treatment of lower urinary tract symptoms in older men. J Urol. 2009;181(4):1779–87.
Oelke M, Bachmann A, Descazeaud A, et al. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol. 2013;64(1):118–40. This is a summary of the 2013 edition of the European Association of Urology guidelines on the treatment and follow-up of male lower urinary tract symptoms.
McNicholas TA, Kirby RS, Lepor H. Evaluation and nonsurgical management of benign prostatic hyperplasia. In: Wein AJ, Kavoussi LR, Novick AC, et al., editors. Campbell-walsh urology. 10th ed. Philadelphia: Elsevier Saunders; 2012.
Thomas AW, Cannon A, Bartlett E, et al. The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic follow-up of transurethral resection of prostate for bladder outlet obstruction. J Urol. 2005;174(5):1887–91.
Lenherr SM, Clemens JQ. Urodynamics: with a focus on appropriate indications. Urol Clin North Am. 2013;40(4):545–57. An excellent review on contemporary indications and techniques for adult urodynamic testing incorporating specific clinical questions and appropriate urodynamic studies addressing the questions along with a discussion on testing pitfalls and appropriate troubleshooting.
Chancellor M. Bladder outlet obstruction versus impaired detrusor contractility: the role of outflow. J Urol. 1991;145(4):810–2.
Oelke M, Baard J, Wijkstra H, et al. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia. Eur Urol. 2008;54(2):419–26.
Abrams P, Cardozo L, Fall M, Standardisation Subcommittee of the International Continence Society, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21:167–78.
Griffiths D, Hbfner K, Van Mastrigt R, et al. Standardization of terminology of lower urinary tract function: Pressure-flow studies of voiding, urethral resistance, and urethral obstruction. International Continence Society Subcommittee on Standardization of Terminology of Pressure-Flow Studies. Neurourol Urodyn. 1997;16:1–18.
Mehdizadeh JL, Leach GE. Role of invasive urodynamic testing in benign prostatic hyperplasia and male lower urinary tract symptoms. Urol Clin North Am. 2009;36(4):431–41. The manuscript addresses the controversy of the role of urodynamic studies in BPH/LUTS notwithstanding the additional information that urodynamic studies provide regarding bladder function and outlet obstruction. The authors discuss the role of urodynamic studies in BPH/LUTS, review best practice guidelines and current literature, and provide recommendations for their use in clinical practice.
Scarpero HM, Padmanabhan P, Xue X, et al. Patient perception of videourodynamic testing: a questionnaire based study. J Urol. 2005;173(2):555–9.
Ku JH, Kim SW, Kim HH, et al. Patient experience with a urodynamic study: a prospective study in 208 patients. J Urol. 2004;171(6):2307–10.
Liao L, Schaefer W. Within-session reproducibility and variability of urethral resistance and detrusor contractility in pressure-flow studies in men with lower urinary tract symptoms. Curr Urol. 2009;3(1):19–28.
Tammela TL, Schäfer W, Barrett DM, et al. Repeated pressure-flow studies in the evaluation of bladder outlet obstruction due to benign prostatic enlargement. Finasteride Urodynamics Study Group. Neurourol Urodyn. 1999;18(1):17–24.
Rosier PF, de la Rosette JJ, Koldewijn EL, et al. Variability of pressure-flow analysis parameters in repeated cystometry in patients with benign prostatic hyperplasia. J Urol. 1995;153(5):1520–5.
Foon R, Toozs-Hobson P, Latthe P. Prophylactic antibiotics to reduce the risk of urinary tract infections after urodynamic studies. Cochrane Datab Syst Rev. 2012;10:CD008224.
Tanaka Y, Masumori N, Itoh N, et al. Is the short-term outcome of transurethral resection of the prostate affected by preoperative degree of bladder outlet obstruction, status of detrusor contractility or detrusor overactivity? Int J Urol. 2006;13((11):1398–404.
Machino R, Kakizaki H, Ameda K, et al. Detrusor instability with equivocal obstruction: a predictor of unfavorable symptomatic outcomes after transurethral prostatectomy. Neurourol Urodyn. 2002;21(5):444–9.
Van Venrooij GE, van Melick HH, Boon TA. Comparison of outcomes of transurethral prostate resection in urodynamically obstructed versus selected urodynamically unobstructed or equivocal men. J Urol. 2003;62(4):672–6.
DiSantostefano R, Biddle A, Lavelle J. An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia. Br J Urol. 2006;97:1007–16.
Compliance with Ethics Guidelines
Conflict of Interest
Hari S.G.R. Tunuguntla and Jaspreet Parihar declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on Voiding Dysfunction Evaluation
Rights and permissions
About this article
Cite this article
Tunuguntla, H.S.G.R., Parihar, J. Urodynamics in Male Lower Urinary Tract Symptoms. Curr Bladder Dysfunct Rep 10, 125–131 (2015). https://doi.org/10.1007/s11884-015-0299-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11884-015-0299-2